Literature DB >> 15850570

Peroxynitrite activates ERK via Raf-1 and MEK, independently from EGF receptor and p21Ras in H9C2 cardiomyocytes.

B Pesse1, S Levrand, F Feihl, B Waeber, B Gavillet, P Pacher, L Liaudet.   

Abstract

Peroxynitrite is a potent oxidant and nitrating species proposed as a direct effector of myocardial damage in a wide range of cardiac diseases. Whether peroxynitrite also acts indirectly, by modulating cell signal transduction pathways in the myocardium, has not been investigated. Here, we examined the ability of peroxynitrite to activate extracellular signal-related kinase (ERK), a MAP kinase which has been linked with hypertrophic and anti-apoptotic responses in the heart, in cultured H9C2 cardiomyocytes. Peroxynitrite elicited a concentration- and time-dependent activation of ERK, secondary to the upstream activation of MEK 1 (ERK kinase). Activation of MEK-ERK by peroxynitrite was related to the upstream activation of Raf-1 kinase, as ERK and MEK phosphorylation were prevented by the Raf-1 inhibitor BAY43-9006. These effects of peroxynitrite were not associated with the activation of p21(Ras), known as a common signaling target of cellular oxidative stress. In contrast to ERK activation mediated by the epidermal growth factor (EGF), ERK activation by peroxynitrite was not prevented by AG1478 (EGF receptor inhibitor). Peroxynitrite acted through oxidative, but not nitrative chemistry, as ERK remained activated while nitration was prevented by the flavanol epicatechin. In addition to ERK, peroxynitrite also potently activated two additional members of the MAP kinase family of signaling proteins, JNK and p38. Thus, peroxynitrite activates ERK in cardiomyocytes through an unusual signaling cascade involving Raf-1 and MEK 1, independently from EGFR and P21(Ras), and also acts as a potent activator of JNK and p38. These results provide the novel concept that peroxynitrite may represent a previously unrecognized signaling molecule in various cardiac pathologies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850570      PMCID: PMC2254583          DOI: 10.1016/j.yjmcc.2005.02.020

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  41 in total

1.  More powerful procedures for multiple significance testing.

Authors:  Y Hochberg; Y Benjamini
Journal:  Stat Med       Date:  1990-07       Impact factor: 2.373

2.  Morphological, biochemical, and electrophysiological characterization of a clonal cell (H9c2) line from rat heart.

Authors:  J Hescheler; R Meyer; S Plant; D Krautwurst; W Rosenthal; G Schultz
Journal:  Circ Res       Date:  1991-12       Impact factor: 17.367

3.  Phosphatidylinositol 3-kinase is required for integrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation.

Authors:  W G King; M D Mattaliano; T O Chan; P N Tsichlis; J S Brugge
Journal:  Mol Cell Biol       Date:  1997-08       Impact factor: 4.272

4.  Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase.

Authors:  M Foschi; S Chari; M J Dunn; A Sorokin
Journal:  EMBO J       Date:  1997-11-03       Impact factor: 11.598

5.  Differential activation of mitogen-activated protein kinases by nitric oxide-related species.

Authors:  H M Lander; A T Jacovina; R J Davis; J M Tauras
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

6.  Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide.

Authors:  R Radi; J S Beckman; K M Bush; B A Freeman
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

7.  Peroxynitrite formation from macrophage-derived nitric oxide.

Authors:  H Ischiropoulos; L Zhu; J S Beckman
Journal:  Arch Biochem Biophys       Date:  1992-11-01       Impact factor: 4.013

8.  MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo.

Authors:  Daniel J Lips; Orlando F Bueno; Benjamin J Wilkins; Nicole H Purcell; Robert A Kaiser; John N Lorenz; Laure Voisin; Marc K Saba-El-Leil; Sylvain Meloche; Jacques Pouysségur; Gilles Pagès; Leon J De Windt; Pieter A Doevendans; Jeffery D Molkentin
Journal:  Circulation       Date:  2004-04-19       Impact factor: 29.690

Review 9.  Poly(ADP-ribose) polymerase activation in the reperfused myocardium.

Authors:  Gábor Szabó; Lucas Liaudet; Siegfried Hagl; Csaba Szabó
Journal:  Cardiovasc Res       Date:  2004-02-15       Impact factor: 10.787

10.  p21ras as a common signaling target of reactive free radicals and cellular redox stress.

Authors:  H M Lander; J S Ogiste; K K Teng; A Novogrodsky
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

View more
  22 in total

1.  Ouabain increases iNOS-dependent nitric oxide generation which contributes to the hypertrophic effect of the glycoside: possible role of peroxynitrite formation.

Authors:  Xiaohong Tracey Gan; J Craig Hunter; Cathy Huang; Jenny Xue; Venkatesh Rajapurohitam; Sabzali Javadov; Morris Karmazyn
Journal:  Mol Cell Biochem       Date:  2011-12-10       Impact factor: 3.396

2.  Peroxynitrite nitrates adenine nucleotide translocase and voltage-dependent anion channel 1 and alters their interactions and association with hexokinase II in mitochondria.

Authors:  Meiying Yang; Yanji Xu; James S Heisner; Jie Sun; David F Stowe; Wai-Meng Kwok; Amadou K S Camara
Journal:  Mitochondrion       Date:  2018-11-01       Impact factor: 4.160

3.  Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Béla Horváth; Sándor Bátkai; Ogyi Park; Galin Tanchian; Rachel Y Gao; Vivek Patel; David A Wink; Lucas Liaudet; György Haskó; Raphael Mechoulam; Pál Pacher
Journal:  Free Radic Biol Med       Date:  2011-03-11       Impact factor: 7.376

4.  Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo.

Authors:  Sandra Levrand; Christine Vannay-Bouchiche; Benoît Pesse; Pal Pacher; François Feihl; Bernard Waeber; Lucas Liaudet
Journal:  Free Radic Biol Med       Date:  2006-06-07       Impact factor: 7.376

5.  Neurovascular protection by ischaemic tolerance: role of nitric oxide.

Authors:  Costantino Iadecola; Timo Kahles; Eduardo F Gallo; Josef Anrather
Journal:  J Physiol       Date:  2011-07-11       Impact factor: 5.182

6.  Peroxynitrite is a potent inhibitor of NF-{kappa}B activation triggered by inflammatory stimuli in cardiac and endothelial cell lines.

Authors:  Sandra Levrand; Benoît Pesse; François Feihl; Bernard Waeber; Pal Pacher; Joëlle Rolli; Marie-Denise Schaller; Lucas Liaudet
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

Review 7.  Oxidative and nitrosative stress and fibrogenic response.

Authors:  R Urtasun; L Conde de la Rosa; N Nieto
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

8.  Bacterial flagellin elicits widespread innate immune defense mechanisms, apoptotic signaling, and a sepsis-like systemic inflammatory response in mice.

Authors:  Joëlle Rolli; Noureddine Loukili; Sandra Levrand; Nathalie Rosenblatt-Velin; Stéphanie Rignault-Clerc; Bernard Waeber; François Feihl; Pal Pacher; Lucas Liaudet
Journal:  Crit Care       Date:  2010-08-24       Impact factor: 9.097

9.  Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Yoshihiro Kashiwaya; György Haskó; Lucas Liaudet; Csaba Szabó; Pál Pacher
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-03-13       Impact factor: 4.733

10.  CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.

Authors:  Partha Mukhopadhyay; Mohanraj Rajesh; Sándor Bátkai; Vivek Patel; Yoshihiro Kashiwaya; Lucas Liaudet; Oleg V Evgenov; Ken Mackie; György Haskó; Pál Pacher
Journal:  Cardiovasc Res       Date:  2009-11-26       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.